Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Diagnostic Value of MRI for Allergic Broncho-Pulmonary Aspergilloses

NCT: NCT03265366 · COMPLETED

NCT IDNCT03265366
StatusCOMPLETED
Start Date2017-09-14
Completion2020-01-24
SponsorUniversity Hospital, Bordeaux (OTHER)
First posted
Last updated

Brief Summary

The aim of the study is to compare the concordance between chest computerized tomography-scan (CTscan) and Magnetic resonance Imaging (MRI) for the description of the abnormalities seen in Allergic BronchoPulmonary Aspergillosis (ABPA).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑